Ribosomal Protein s15 Phosphorylation Mediates LRRK2 Neurodegeneration in Parkinson’s Disease

Anand, 2009, Investigation of leucine-rich repeat kinase 2 : enzymological properties and novel assays, FEBS J., 276, 466, 10.1111/j.1742-4658.2008.06789.x Belin, 2010, Purification of ribosomes from human cell lines, Curr. Protoc. Cell Biol., Chapter 3, 10.1002/0471143030.cb0340s49 Bhakar, 2012, The pathophysiology of fragile X (and what it teaches us about synapses), Annu. Rev. Neurosci., 35, 417, 10.1146/annurev-neuro-060909-153138 Chartier-Harlin, 2011, Translation initiator EIF4G1 mutations in familial Parkinson disease, Am. J. Hum. Genet., 89, 398, 10.1016/j.ajhg.2011.08.009 Cookson, 2010, The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson’s disease, Nat. Rev. Neurosci., 11, 791, 10.1038/nrn2935 Covy, 2009, Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2, Biochem. Biophys. Res. Commun., 378, 473, 10.1016/j.bbrc.2008.11.048 Deng, 2011, Characterization of a selective inhibitor of the Parkinson’s disease kinase LRRK2, Nat. Chem. Biol., 7, 203, 10.1038/nchembio.538 Gehrke, 2010, Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression, Nature, 466, 637, 10.1038/nature09191 Greggio, 2006, Kinase activity is required for the toxic effects of mutant LRRK2/dardarin, Neurobiol. Dis., 23, 329, 10.1016/j.nbd.2006.04.001 Imai, 2008, Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila, EMBO J., 27, 2432, 10.1038/emboj.2008.163 Khairulina, 2010, Eukaryote-specific motif of ribosomal protein S15 neighbors A site codon during elongation and termination of translation, Biochimie, 92, 820, 10.1016/j.biochi.2010.02.031 Kumar, 2010, The Parkinson’s disease associated LRRK2 exhibits weaker in vitro phosphorylation of 4E-BP compared to autophosphorylation, PLoS ONE, 5, e8730, 10.1371/journal.pone.0008730 Lagier-Tourenne, 2012, Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs, Nat. Neurosci., 15, 1488, 10.1038/nn.3230 Lee, 2010, Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson’s disease, Nat. Med., 16, 998, 10.1038/nm.2199 Li, 2010, Reevaluation of phosphorylation sites in the Parkinson disease-associated leucine-rich repeat kinase 2, J. Biol. Chem., 285, 29569, 10.1074/jbc.M110.127639 Liu, 2008, A Drosophila model for LRRK2-linked parkinsonism, Proc. Natl. Acad. Sci. USA, 105, 2693, 10.1073/pnas.0708452105 Luzón-Toro, 2007, Mechanistic insight into the dominant mode of the Parkinson’s disease-associated G2019S LRRK2 mutation, Hum. Mol. Genet., 16, 2031, 10.1093/hmg/ddm151 MacLeod, 2006, The familial Parkinsonism gene LRRK2 regulates neurite process morphology, Neuron, 52, 587, 10.1016/j.neuron.2006.10.008 Martin, 2011, Recent advances in the genetics of Parkinson’s disease, Annu. Rev. Genomics Hum. Genet., 12, 301, 10.1146/annurev-genom-082410-101440 Matta, 2012, LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis, Neuron, 75, 1008, 10.1016/j.neuron.2012.08.022 Moreno, 2012, Sustained translational repression by eIF2α-P mediates prion neurodegeneration, Nature, 485, 507, 10.1038/nature11058 Nuytemans, 2013, Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease, Neurology, 80, 982, 10.1212/WNL.0b013e31828727d4 Paisán-Ruíz, 2004, Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease, Neuron, 44, 595, 10.1016/j.neuron.2004.10.023 Parisiadou, 2009, Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis, J. Neurosci., 29, 13971, 10.1523/JNEUROSCI.3799-09.2009 Pisarev, 2006, Specific functional interactions of nucleotides at key -3 and +4 positions flanking the initiation codon with components of the mammalian 48S translation initiation complex, Genes Dev., 20, 624, 10.1101/gad.1397906 Polymenidou, 2011, Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43, Nat. Neurosci., 14, 459, 10.1038/nn.2779 Ramsden, 2011, Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson’s disease-related toxicity in human neurons, ACS Chem. Biol., 6, 1021, 10.1021/cb2002413 Scheper, 2007, Translation matters: protein synthesis defects in inherited disease, Nat. Rev. Genet., 8, 711, 10.1038/nrg2142 Sen, 2009, Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization, J. Biol. Chem., 284, 36346, 10.1074/jbc.M109.025437 Smith, 2006, Kinase activity of mutant LRRK2 mediates neuronal toxicity, Nat. Neurosci., 9, 1231, 10.1038/nn1776 Tain, 2009, Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss, Nat. Neurosci., 12, 1129, 10.1038/nn.2372 Thoreen, 2012, A unifying model for mTORC1-mediated regulation of mRNA translation, Nature, 485, 109, 10.1038/nature11083 Tollervey, 2011, Characterizing the RNA targets and position-dependent splicing regulation by TDP-43, Nat. Neurosci., 14, 452, 10.1038/nn.2778 Trancikova, 2012, Phosphorylation of 4E-BP1 in the mammalian brain is not altered by LRRK2 expression or pathogenic mutations, PLoS ONE, 7, e47784, 10.1371/journal.pone.0047784 Tsika, 2012, Mechanisms of LRRK2-mediated neurodegeneration, Curr. Neurol. Neurosci. Rep., 12, 251, 10.1007/s11910-012-0265-8 Webber, 2011, Autophosphorylation in the leucine-rich repeat kinase 2 (LRRK2) GTPase domain modifies kinase and GTP-binding activities, J. Mol. Biol., 412, 94, 10.1016/j.jmb.2011.07.033 West, 2007, Parkinson’s disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity, Hum. Mol. Genet., 16, 223, 10.1093/hmg/ddl471 Xiong, 2010, GTPase activity plays a key role in the pathobiology of LRRK2, PLoS Genet., 6, e1000902, 10.1371/journal.pgen.1000902 Zimprich, 2004, Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology, Neuron, 44, 601, 10.1016/j.neuron.2004.11.005 Gargano, 2005, Rapid iterative negative geotaxis (RING): a new method for assessing age-related locomotor decline in Drosophila, Exp. Gerontol., 40, 386, 10.1016/j.exger.2005.02.005 Kriks, 2011, Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease, Nature, 480, 547, 10.1038/nature10648 Paşca, 2011, Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome, Nat. Med., 17, 1657, 10.1038/nm.2576 Shayakhmetov, 2010, Recognition of virus infection and innate host responses to viral gene therapy vectors, Mol. Ther., 18, 1422, 10.1038/mt.2010.124 Suzuki, 2007, Early STAT1 activation after systemic delivery of HSV amplicon vectors suppresses transcription of the vector-encoded transgene, Mol. Ther., 15, 2017, 10.1038/sj.mt.6300273 Suzuki, 2008, Stable transgene expression from HSV amplicon vectors in the brain: potential involvement of immunoregulatory signals, Mol. Ther., 16, 1727, 10.1038/mt.2008.175 Wu, 2006, A protocol for dissecting Drosophila melanogaster brains for live imaging or immunostaining, Nat. Protoc., 1, 2110, 10.1038/nprot.2006.336 Yahata, 2011, Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer’s disease, PLoS ONE, 6, e25788, 10.1371/journal.pone.0025788